Bronchodilator therapy forms the mainstay of treatment for people with COPD. Bronchodilators work by altering the airways’ smooth muscle tone, leading to widening of the airways, which ...

This study demonstrates that there is no benefit of inhaled short-acting ß-agonists prior to bronchoscopy in patients with COPD. The inhalation of salbutamol neither improved safety nor prevented ...

These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare provider ...

N-acetylcysteine (NAC) nebulizer therapy is effective and safe as a short-term (12-week) treatment for reducing phlegm in chronic obstructive pulmonary disease (COPD), according to study findings ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, shares the latest clinical discoveries from the BOREAS trial on type 2 inflammation in patients with chronic ...

DirectRx pharmacy was added to the network of pharmacies distributing newly approved COPD therapy Ohtuvayre (ensifentrine) in ...

Famed filmmaker David Lynch, 78, says that while he loved everything about smoking, he stopped two years ago after being ...

GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management.

Adults who did not meet the critical smoking exposure threshold of smoking less than 10 pack-years still had greater risk for COPD and early death.

AstraZeneca executives say they are “not worried” that the failure of tozorakimab in a phase 2 chronic obstructive pulmonary ...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Verona Pharma (VRNA – Research Report), with a ...

Dupixent data reinforce clinically meaningful benefit from pooled analysis of two COPD phase 3 studies: Paris Wednesday, September 11, 2024, 16:00 Hrs [IST] A pooled analysis from ...